Pfizer Inc (PFIZ34) — Capital Reinvestment Ratio
Pfizer Inc (PFIZ34) has a Capital Reinvestment Ratio of 0.64x as of June 2026, meaning it reinvests 1% of its operating cash flow (R$835.00 Million) in capital expenditures (R$533.00 Million). Check how tangible is Pfizer Inc's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Pfizer Inc Capital Reinvestment Ratio (2014–2025)
This chart tracks Pfizer Inc's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see Pfizer Inc (PFIZ34) cash conversion ratio.
Annual Capital Reinvestment Ratio for Pfizer Inc (2014–2025)
Year-by-year Capital Reinvestment Ratio for Pfizer Inc from 2014 to 2025. See how much free cash does Pfizer Inc generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (BRL) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | R$11.71 Billion | R$2.63 Billion | ▼ -1.6% |
| 2024 | 0.23x | R$12.74 Billion | R$2.91 Billion | ▼ -28.9% |
| 2023 | 0.32x | R$12.04 Billion | R$3.86 Billion | ▲ +190.2% |
| 2022 | 0.11x | R$29.27 Billion | R$3.24 Billion | ▲ +32.9% |
| 2021 | 0.08x | R$32.58 Billion | R$2.71 Billion | ▼ -57.1% |
| 2020 | 0.19x | R$14.40 Billion | R$2.79 Billion | ▼ -6.0% |
| 2019 | 0.21x | R$12.59 Billion | R$2.59 Billion | ▲ +48.5% |
| 2018 | 0.14x | R$15.83 Billion | R$2.20 Billion | ▲ +5.2% |
| 2017 | 0.13x | R$16.80 Billion | R$2.22 Billion | ▲ +6.9% |
| 2016 | 0.12x | R$16.19 Billion | R$2.00 Billion | ▲ +29.8% |
| 2015 | 0.10x | R$14.69 Billion | R$1.40 Billion | ▲ +35.5% |
| 2014 | 0.07x | R$17.08 Billion | R$1.20 Billion | — |